Article contents
Central IRB Review Is an Essential Requirement for Cancer Clinical Trials
Published online by Cambridge University Press: 01 January 2021
Abstract
There are compelling medical, ethical, and legal arguments that support mandating use of a central institutional review board (CIRB) for the review of clinical trials performed at multiple institutional sites. Progress against serious diseases depends on this.
- Type
- Symposium Articles
- Information
- Journal of Law, Medicine & Ethics , Volume 45 , Issue 3: Symposium - Controversies in Clinical Research Ethics , Fall 2017 , pp. 341 - 347
- Copyright
- Copyright © American Society of Law, Medicine and Ethics 2017
References
- 2
- Cited by